Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Ewing's sarcoma and related subtypes of primitive neuroectodermal tumours share a recurrent and specific t(11;22) (q24;q12) chromosome translocation, the breakpoints of which have recently been cloned. Phylogenetically conserved restriction fragments in the vicinity of EWSR1 and EWSR2, the genomic regions where the breakpoints of chromosome 22 and chromosome 11 are, respectively, have allowed identification of transcribed sequences from these regions and has indicated that a hybrid transcript might be generated by the translocation. Here we use these fragments to screen human complementary DNA libraries to show that the translocation alters the open reading frame of an expressed gene on chromosome 22 gene by substituting a sequence encoding a putative RNA-binding domain for that of the DNA-binding domain of the human homologue of murine Fli-1.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ewing’s sarcoma, a common pediatric cancer, is invariably associated with ETS gene translocations (182) that result in a fusion oncogene consisting of the 5′ end of EWS and the 3′ end of FLI1, or less frequently ERG, ETV1, ETV4, or FEV (Figure 1a) (183, 184).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [183]
Citations
Cites
Kozak, M. (1986) · Cell · doi:10.1016/0092-8674(86)90762-2 · Cited by 4,741
Transcriptional Regulation in Mammalian Cells by Sequence-Specific DNA Binding Proteins
Mitchell, P. J., & Tjian, R. (1989) · Science · doi:10.1126/science.2667136 · Cited by 3,114
RNA recognition: towards identifying determinants of specificity
Kenan, D. J., Query, C. C., & Keene, J. D. (1991) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(91)90088-d · Cited by 730
RNA-binding proteins as developmental regulators.
Bandziulis, R. J., Swanson, M. S., & Dreyfuss, G. (1989) · Genes & Development · doi:10.1101/gad.3.4.431 · Cited by 644
Turc-Carel, C., Aurias, A., Mugneret, F., Lizard, S., Sidaner, I., Volk, C., Thiery, J. P., Olschwang, S., Philip, I., Berger, M. P., et al. (1988) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(88)90285-3 · Cited by 466
Self-citationBen-David, Y., Giddens, E. B., Letwin, K., & Bernstein, A. (1991) · Genes & Development · doi:10.1101/gad.5.6.908 · Cited by 403
Chromosome Translocation in Peripheral Neuroepithelioma
Whang-Peng, J., Triche, T. J., Knutsen, T., Miser, J., Douglass, E. C., & Israel, M. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408303110907 · Cited by 399
Chromosomal Translocations in Ewing's Sarcoma
(1983) · New England Journal of Medicine · doi:10.1056/nejm198308253090817 · Cited by 330
Corden, J. L. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90236-5 · Cited by 327
Turc-Carel, C., Philip, I., Berger, M.-P., Philip, T., & Lenoir, G. M. (1984) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(84)90002-5 · Cited by 291
Research works printed but not linked: 8
- Aurias, A., Rimbaut, C., Buffe, C., Dubousset, J. & Mazabraud, A. N. Engl. J. Med. 309, 496–497 (1983).
- Turc-Carel, C., Philip, I., Berge, R. M. P., Philip, T. & Lenoir, G. M. N. Engl. J. Med. 309, 497–498 (1983).
- De Chadarevian, J. P., Vekemans, M. & Seemayer, T. A. N. Engl. J. Med. 311, 1702–1703 (1984).
- Cavazzana, A. O. et al. Adv. Neuroblastoma Res. 2, 463–473 (1988).
- Zucman, J. et al. Genes Chrom. Cancer (in the press).
- Douglass, E. C., Valentine, M., Green, A. A., Hayes, F. A. & Thompson, E. I. J. natn. Cancer Inst. 77, 1211–1213 (1986).
- Watson, D. K., Ascione, R. & Papas, T. S. Crit. Rev. Oncogenesis 1, 409–436 (1990).
- Rouleau, G. A. et al. Am. J. hum. Genet. 46, 323–328 (1990).
Cited by
Items 901–1,000 of 1,002
Moritake, H., Saito, Y., Sawa, D., Sameshima, N., Yamada, A. Y., Kinoshita, M., Kamimura, S., Konomoto, T., & Nunoi, H. (2019) · Cancer Medicine · doi:10.1002/cam4.2647 · Cited by 25
Vellichirammal, N. N., Chaturvedi, N. K., Joshi, S. S., Coulter, D. W., & Guda, C. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.11.015 · Cited by 26
Precision medicine in pediatric solid cancers
Blattner-Johnson, M., Jones, D., & Pfaff, E. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.06.008 · Cited by 30
Nishizawa, N., Kumamoto, Y., Igarashi, K., Nishiyama, R., Tajima, H., Kawamata, H., Kaizu, T., & Watanabe, M. (2015) · Surgical Case Reports · doi:10.1186/s40792-015-0084-7 · Cited by 25
“Meanwhile, the 3′ sides of a fusion gene are known as FLI1 t(11:22) (80–85 %), ERG t(21:22) (5–15 %), ETV1 t(7:22) (rare), E1AF t(17:22) (rare), and FEV t(2:22) (rare) [28, 29].”
Notch signaling in pediatric soft tissue sarcomas
Rota, R., Ciarapica, R., Miele, L., & Locatelli, F. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-141 · Cited by 27
Ewing sarcoma family of tumors: a model for the new era of integrated laboratory diagnostics
Khoury, J. D. (2007) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.8.1.97 · Cited by 25
Yap, T. A., Olmos, D., Molife, L. R., & Bono, J. S. D. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.602630 · Cited by 26
“The IGF system also consists of six binding proteins (IGFBPs) and IGFBP proteases [17].”
BackgroundInfluentialEWSR1-FLI1 Activation of the Cancer/Testis Antigen FATE1 Promotes Ewing Sarcoma Survival
Gallegos, Z. R., Taus, P., Gibbs, Z. A., McGlynn, K., Gomez, N. C., Davis, I. J., & Whitehurst, A. W. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00138-19 · Cited by 25
The clinical role of molecular genetics in soft tissue tumor pathology
BUSAM, K. J., & Fletcher, C. D. �. (1997) · Cancer and Metastasis Reviews · doi:10.1023/a:1005721114555 · Cited by 25
The ETS Family Member Tel Antagonizes the Fli-1 Phenotype in Hematopoietic Cells
Kwiatkowski, B. A., Zielinska‐Kwiatkowska, A., Bauer, T. R., & Hickstein, D. D. (2000) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2000.0282 · Cited by 31
Li, X., Tanaka, K., Nakatani, F., Matsunobu, T., Sakimura, R., Hanada, M., Okada, T., Nakamura, T., & Iwamoto, Y. (2005) · International Journal of Cancer · doi:10.1002/ijc.21010 · Cited by 28
“This results in the formation of EWS-Fli1 gene fusion, which produces EWS-Fli1 fusion protein.(2) EWS-Fli1 functions as an aberrant transcriptional activator, which may be responsible for the tumorigenesis of EFTs.”
BackgroundEwingʼs Sarcoma—A Clinical Enigma Coming Into Focus
Denny, C. T. (1998) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199809000-00002 · Cited by 28
Kurahashi, H., Akagi, K., Karakawa, K., Nakamura, T., Dumanski, J. P., Sano, T., Okada, S., Takai, S.-I., & Nishisho, I. (1994) · Human Genetics · doi:10.1007/bf00212017 · Cited by 25
The cytogenetic and molecular characterization of benign and malignant soft tissue tumors
Sreekantaiah, C. (1998) · Cytogenetic and Genome Research · doi:10.1159/000015056 · Cited by 27
“It appears, however, to encode an RNA-binding domain in its C-terminal portion and a region with transcriptional activating properties in its N-terminal half (Delattre et al., 1992; Ohno et al., 1993, 1994; Burd and Dreyfuss, 1994).”
BackgroundStark, B., Mor, C., Jeison, M., Gobuzov, R., Cohen, I. J., Goshen, Y., Stein, J., Fisher, S., Ash, S., Yaniv, I., et al. (1997) · Journal of Neuro-Oncology · doi:10.1023/a:1005731009962 · Cited by 25
Seidel, M. G., Kashofer, K., Moser, T., Thueringer, A., Liegl-Atzwanger, B., Leithner, A., Szkandera, J., Benesch, M., El-Heliebi, A., & Heitzer, E. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.926405 · Cited by 24
Liu, C., Liu, Y., Zhao, Y., Wei, J., Ma, Y., Liu, Y., & Huang, J. (2020) · World Neurosurgery · doi:10.1016/j.wneu.2020.07.015 · Cited by 24
Grissenberger, S., Sturtzel, C., Wenninger-Weinzierl, A., Radic-Sarikas, B., Scheuringer, E., Bierbaumer, L., Etienne, V., Némati, F., Pascoal, S., Tötzl, M., et al. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.216028 · Cited by 27
Self-citationRegulation of EWSR1-FLI1 Function by Post-Transcriptional and Post-Translational Modifications
Yu, L., Davis, I. J., & Liu, P. (2023) · Cancers · doi:10.3390/cancers15020382 · Cited by 27
EWSR1 maintains centromere identity
Kitagawa, R., Niikura, Y., Becker, A., Houghton, P. J., & Kitagawa, K. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112568 · Cited by 25
YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model
Minas, T. Z., Han, J., Javaheri, T., Hong, S.-H., Schlederer, M., Saygideğer-Kont, Y., Çelik, H., Mueller, K. M., Temel, I., Özdemirli, M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5520 · Cited by 23
Self-citationCell cycle inhibition and apoptosis induced by curcumin in Ewing sarcoma cell line SK-NEP-1
Singh, M., Pandey, A., Karikari, C. A., Singh, G., & Rakheja, D. (2009) · Medical Oncology · doi:10.1007/s12032-009-9341-6 · Cited by 24
“Ewing sarcoma family of tumors is the second most common bone malignancy in children and adolescents with mean age of diagnosis around 14 years [1, 2 ]. Five-year event-free survival rate for patients with localized disease at the time of presentation is approximately 70% using combination of local therapy and systemi…”
BackgroundGautam, U., Srinivasan, R., Rajwanshi, A., Bansal, D., Marwaha, R. K., & Vasishta, R. K. (2010) · American Journal of Clinical Pathology · doi:10.1309/ajcppjj0py4xzoec · Cited by 24
Ibrahim, G. M., Fallah, A., Shahideh, M., Tabori, U. Y., & Rutka, J. T. (2011) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2011.06.001 · Cited by 24
Modeling the initiation of Ewing sarcoma tumorigenesis in differentiating human embryonic stem cells
Gordon, D. J., Motwani, M., & Pellman, D. S. (2015) · Oncogene · doi:10.1038/onc.2015.368 · Cited by 29
The EWS protein is dispensable for Ewing tumor growth.
Kovar, H., Jug, G., Hattinger, C. M., Spahn, L., Aryee, D. N. T., Ambros, P. F., Zoubek, A., & Gadner, H. (2001) · PubMed · Cited by 34
Self-citationIs Ewing's Sarcoma a Stem Cell Tumor?
Meltzer, P. S. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.011 · Cited by 24
“At the molecular level, this translocation creates a fusion gene encoding a chimeric oncoprotein containing segments of two nuclear proteins: EWS (EWSR1) and the ets family transcription factor FLI1 (Delattre et al., 1992).”
BackgroundSchultze–Mosgau, S., Thorwarth, M. W., Wehrhan, F., Holter, W., Stachel, D., Grabenbauer, G. G., Amann, K., & Beck, J. D. (2005) · Journal of Craniofacial Surgery · doi:10.1097/01.scs.0000180005.52986.19 · Cited by 24
Wang, Y., Einhorn, P. A., Triche, T. J., Seeger, R. C., & Reynolds, C. P. (2000) · PubMed · Cited by 24
Abadie, A., Besançon, F., & Wietzerbin, J. (2004) · Oncogene · doi:10.1038/sj.onc.1207614 · Cited by 25
“An internal standard EWS/FLI1 transcript of 495 bp (Delattre et al., 1992) was used to normalize PCR products that were resolved on a 2% agarose gel and visualized in the presence of ethidium bromide using a densitometric video camera (Imager, Appligene, Illkirch, France).”
BackgroundMethodBACKER, A., Mount, S. L., Zarka, M. A., Trask, C. E., Allen, E. F., Gerald, W. L., Sanders, D. A., & Weaver, D. L. (1998) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280050147 · Cited by 24
“Molecular studies have shown this translocation results in the fusion of the EWS gene on chromosome 22 with the FLI-1 gene from 11q24 [ 5 ].”
BackgroundHuman FLI-1 localizes to chromosome 11Q24 and has an aberrant transcript in neuroepithelioma
Hromas, R., May, W., Denny, C. T., Raskind, W. H., Moore, J., Maki, R. A., Beck, E., & Klemsz, M. J. (1993) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(93)90283-j · Cited by 27
Lee, C. S., Southey, M. C., Waters, K., Kannourakis, G., Georgiou, T., Armes, J. E., Chow, C. W., & Venter, D. J. (1996) · Pediatric Pathology & Laboratory Medicine · doi:10.1080/15513819609168678 · Cited by 24
Ten years of the cytogenetics of soft tissue tumors
Cin, P. D., & BERGHE, H. V. D. (1997) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(96)00271-3 · Cited by 24
MiR-30 family: a novel avenue for treating bone and joint diseases?
Huang, J., Li, Y., Zhu, S., Wang, L., Yang, L., & He, C. (2023) · International Journal of Medical Sciences · doi:10.7150/ijms.81990 · Cited by 23
“Eighty-five percent of cases are characterized by a recurrent chromosome t(11;22)(q24;q12) translocation, which leads to fusions between the EWS and FLI1 genes and overexpression of the EWS-FLI1 aberrant transcription factor [61]; therefore, EWS-FLI1 is a critical biomarker and therapeutic target in ES.”
Origin of Ewing sarcoma by embryonic reprogramming of neural crest to mesoderm
Vasileva, E., Arata, C., Luo, Y., Burgos, R., Crump, J. G., & Amatruda, J. F. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116376 · Cited by 26
A decade in banking Ewing sarcoma: a report from the Children’s Oncology Group
Borinstein, S. C. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00057 · Cited by 23
“In over 85% of cases the translocation occurs between chromosomes 11 and 22 resulting in the creation of a pathognomonic chimeric fusion gene, EWSR1/FLI1 that encodes the EWS/FLI protein (Delattre et al., 1992).”
BackgroundLi, M., & Chen, C.-W. D. (2022) · Biomedicines · doi:10.3390/biomedicines10061325 · Cited by 25
“Since EWSR1-FLI1 was identified in the 1990s [9], many studies have shown that the fusion protein EWSR1-FLI1 is often the only genetic alteration detected in EwS and that EWSR1-FLI1 expression is sufficient to lead to the onset and progression of EwS.”
BackgroundNK2 homeobox gene cluster: Functions and roles in human diseases
Mio, C., Baldan, F., & Damante, G. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2022.10.001 · Cited by 25
“Most cases of Ewing sarcoma show the presence of the recurrent chromosomal translocation t(11; 22) (q24; q12), which encodes the aberrant fusion protein EWS/FLI that acts as a transcription factor able to dysregulate the expression of relevant genes involved in the development of this tumor type.(106,107) By using a s…”
BackgroundLoschi, S., Dufour, C., Oberlin, O., Goma, G., Valteau‐Couanet, D., & Gaspar, N. (2015) · Bone Marrow Transplantation · doi:10.1038/bmt.2015.118 · Cited by 23
Cytogenetic biomarkers for human cancer
Keen‐Kim, D., Nooraie, F., & Rao, P. N. (2008) · Frontiers in bioscience · doi:10.2741/3127 · Cited by 32
“The EWSR1 gene encodes a serine- tyrosine kinase, and the FL1 gene encodes a member of the ETS transcription factor family (144).”
BackgroundPI3K/AKT signaling modulates transcriptional expression of EWS/FLI1 through specificity protein 1
Giorgi, C., Boro, A., Rechfeld, F., Lopez-Garcia, L. A., Gierisch, M. E., Schäfer, B. W., & Niggli, F. K. (2015) · Oncotarget · doi:10.18632/oncotarget.5000 · Cited by 25
Thiel, U., Wawer, A., von Luettichau, I., Bender, H., Blaeschke, F., Grünewald, T. G. P., Steinborn, M., Röper, B., Bonig, H. B., Klingebiel, T. E., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10938 · Cited by 23
“Ewing sarcomas are defined by t(11;22)(q24;q12) derived EWS/ETS fusion oncogenes [1].”
BackgroundSvetoni, F., Paola, E. D., Rosa, P. L., Mercatelli, N., Caporossi, D., Sette, C., & Paronetto, M. P. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx160 · Cited by 25
“generating in frame fusions of the first part of FET genes (encoding the transcription activation domain) with genes encoding transcription factors of the ETS family (7-9).”
BackgroundMok, G. F., Folkes, L., Weldon, S., Maniou, E., Martinez-Heredia, V., Godden, A. M., Williams, R. M., Sauka‐Spengler, T., Wheeler, G. N., Moxon, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21426-7 · Cited by 25
Sengupta, A., Rahman, M. H., Mateo‐Lozano, S., Tirado, Ò. M., & Notario, V. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2016 · Cited by 24
“In order to determine the efficacy of this compound on EWS cells, we examined dose-dependent effects of thiostrepton on the proliferation and/or viability of EWS cell lines A4573, SK-ES-1 and TC-71, selected as representative of the three major EWS/FLI1 translocation types (1).”
BackgroundInfluentialEwing’s Sarcoma Family of Tumors
van Valen, F. (2002) · Human cell culture · doi:10.1007/0-306-46872-7_3 · Cited by 25
Toub, N., Bertrand, J., Malvy, C., Fattal, E., & Couvreur, P. (2006) · Oligonucleotides · doi:10.1089/oli.2006.16.158 · Cited by 23
“…tumors (EFT) (Askin’s tumor of the chest wall, Ewing’s sarcoma, and the primitive peripheral neuroectodermal tumor, neuroepithelioma) share histologic features as well as a recurrent and specific t(11;22) (q24;q12) chromosome translocation present in 85%–90% of these tumors (Desmaze et al., 1992).”
Cytogenetic abnormalities are frequent in uncultured prostate cancer cells
Webb, H., Hawkins, A. L., & Griffin, C. A. (1996) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(95)00305-3 · Cited by 23
Chang, L.-S., Oblinger, J. L., Burns, S. S., Huang, J., Anderson, L. W., Hollingshead, M. G., Shen, R., Pan, L., Agarwal, G., Ren, Y., et al. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0809 · Cited by 22
“Intriguingly, the oncogenic fusion protein EWS-FLI1, which acts as an aberrant transcription factor in Ewing sarcoma (35), was not affected in Roc- and DDR-treated TC32 Ewing sarcoma cells (Fig.”
BackgroundBerger, A. K., Mughal, S. S., Allgäuer, M., Springfeld, C., Hackert, T., Weber, T. F., Naumann, P., Hutter, B., Horak, P., Jahn, A., et al. (2020) · Pancreatology · doi:10.1016/j.pan.2020.02.017 · Cited by 22
Cidre‐Aranaz, F., Li, J., Hölting, T. L. B., Orth, M. F., Imle, R., Kutschmann, S., Ammirati, G. E. M., Ceranski, A. K., Carreño-Gonzalez, M. J., Kasan, M., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-021-01470-z · Cited by 29
Agnoletto, C., Pignochino, Y., Caruso, C., & Garofalo, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065159 · Cited by 23
“ES is characterized by highly recurrent translocations involving ETS transcription factors, with EWS-FLI1 and EWS-ERG being the most common [72,73].”
BackgroundRamon, A.-L., Bertrand, J., de Martimprey, H., Bernard, G., Ponchel, G., Malvy, C., & Vauthier, C. (2013) · Journal of Molecular Recognition · doi:10.1002/jmr.2276 · Cited by 22
“We evaluated the ability of a siRNA associated with the targeted immunonanoparticles to inhibit expression of EWS/Fli-1, which is considered to be the main genetic cause of Ewing’s sarcoma (Turc-Carel et al., 1984; Delattre et al., 1992).”
BackgroundMethodDiagnostic Significance and Clinical Applications of Chimeric Genes in Ewing's Sarcoma
Yoshino, N., Kojima, T., Asami, S., Motohashi, S., Yoshida, Y., Chin, M., Shichino, H., Yoshida, Y., Nemoto, N., Kaneko, M., et al. (2003) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.26.585 · Cited by 22
Cytotoxic T-Lymphocyte Antigen-4 Polymorphisms and Susceptibility to Ewing's Sarcoma
Yang, S., Wang, C., Zhou, Y., Sun, G., Zhu, D., & Gao, S. (2012) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2012.0129 · Cited by 22
“This translocation fuses the EWSR1 gene on chromosome 22 to the FLI1 gene on chromosome 11 and encodes the EWS/FLI fusion protein (Delattre et al. , 1992).”
Diagnostic and Prognostic Sarcoma Signatures
Davicioni, E., Wai, D., & Anderson, M. J. (2008) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256302 · Cited by 26
Borinstein, S. C., Barkauskas, D. A., Krailo, M., Scher, D., Scher, L., Schlottmann, S., Kallakury, B., Dickman, P. S., Pawel, B., West, D. C., et al. (2011) · Cancer · doi:10.1002/cncr.26112 · Cited by 23
“This abnormality is identified in 85% of patients.(5) The product of this fusion gene, known as the EWS-FLI1 oncoprotein, is required for pathogenesis; however, it is not always sufficient independently to promote tumor formation, and additional mutations are required to evade EWS-FLI1–induced cellular senescence.”
BackgroundMAFB enhances oncogenic Notch signaling in T cell acute lymphoblastic leukemia
Pajcini, K. V., Xu, L., Shao, L., Petrovic, J., Palasiewicz, K., Ohtani, Y., Bailis, W., Lee, C., Wertheim, G. B. W., Mani, R., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aam6846 · Cited by 25
“ETS transcription factors are also dysregulated in multiple cancers, including Ewing’s sarcoma (17) and prostate cancer (18).”
BackgroundFusion of the Genes EWSR1 and PBX3 in Retroperitoneal Leiomyoma with t(9;22)(q33;q12)
Panagopoulos, I., Gorunova, L., Bjerkehagen, B., & Heim, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124288 · Cited by 22
“Previously, EWSR1 has been found to be pathogenetically rearranged in the benign hidradenoma of the skin, myoepithelioma, and hemangioma of bone [8, 9, 11, 12], in addition to its much more common involvement in malignant tumors such as the Ewing family of tumors, desmoplastic small round cell tumor, myxoid liposarcom…”
BackgroundEmerging Chemotherapeutic Strategies and the Role of Treatment Stratification in Ewing Sarcoma
Seddon, B. M., & Whelan, J. (2008) · Pediatric Drugs · doi:10.2165/00148581-200810020-00004 · Cited by 23
Przybył, J., Kozak, K., Koseła-Paterczyk, H., Falkowski, S., Świtaj, T., Ługowska, I., Szumera‐Ciećkiewicz, A., Ptaszyński, K., Grygalewicz, B., Chechlińska, M., et al. (2014) · Medical Oncology · doi:10.1007/s12032-014-0109-2 · Cited by 23
“FLI1 (Friend leukemia virus integration 1, also known as EWSR2) and ERG [v-ets erythroblastosis virus E26 oncogene homolog (avian)] are closely related members of the erythroblast transformation-specific (ETS) family of transcription factors, containing ETS-type DNA-binding domain [15, 16].”
BackgroundMerkes, C. M., Turkalo, T. K., Nicole, W., Park, H., Wenger, L. W., Lewin, S. J., & Azuma, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116627 · Cited by 24
“Second, only a single EWS allele is retained in Ewing sarcoma cells due to the generation of EWS/FLI1 by chromosomal translocation, which may induce haploinsufficiency.”
InfluentialFactors Affecting EWS-FLI1 Activity in Ewing's Sarcoma
Herrero‐Martín, D., Fourtouna, A., Niedan, S., Riedmann, L. T., Schwentner, R., & Aryee, D. N. T. (2011) · Sarcoma · doi:10.1155/2011/352580 · Cited by 26
“They are genetically characterized by EWS-ETS gene rearrangements affecting EWSR1 and genes of the ETS-family of transcription factors, predominantly FLI1 characterizing 85% of cases [1].”
BackgroundFukushima, T., Miyazaki, Y., Tsushima, H., Tsutsumi, C., Taguchi, J., Yoshida, S., Kuriyama, K., Scadden, D. T., Nimer, S. D., & Tomonaga, M. (2003) · Leukemia Research · doi:10.1016/s0145-2126(02)00214-x · Cited by 23
Franzius, C., Hotfilder, M., Poremba, C., Hermann, S., Schäfers, K. P., Gabbert, H. E., Jürgens, H., Schober, O., Schäfers, M. A., & Vormoor, J. H. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0106-6 · Cited by 22
Functions and Clinical Significance of Super-Enhancers in Bone-Related Diseases
Qu, J., Ouyang, Z., Wu, W., Li, G., Wang, J., Lu, Q., & Li, Z. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00534 · Cited by 22
“The main known carcinogenic event in Ewing sarcoma is somatic chromosomal translocation that occurs most commonly between chromosomes 11 and 22 and results in a fusion between the 5 region of the EWS gene and the 3 region of the ETS family gene FLI1 (Delattre et al., 1992).”
BackgroundInfluentialRegulation of Metastasis in Ewing Sarcoma
Li, M., & Chen, C.-W. D. (2022) · Cancers · doi:10.3390/cancers14194902 · Cited by 23
Children's Oncology Group's 2023 blueprint for research: Bone tumors
Reed, D. R., Grohar, P. J., Rubin, E. M., Binitie, O. T., Krailo, M., Davis, J. L., DuBois, S. G., & Janeway, K. A. (2023) · Pediatric Blood & Cancer · doi:10.1002/pbc.30583 · Cited by 25
Co-targeting JAK1/STAT6/GAS6/TAM signaling improves chemotherapy efficacy in Ewing sarcoma
Yu, L., Deng, Y., Wang, X., Santos, C., Davis, I. J., Earp, H. S., & Liu, P. (2024) · Nature Communications · doi:10.1038/s41467-024-49667-2 · Cited by 23
How to drug a cloud? Targeting intrinsically disordered proteins
Uversky, V. N. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.124.001113 · Cited by 23
Miao, J., & Chong, S. (2024) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2024.102285 · Cited by 23
VGLL fusions define a new class of intraparenchymal central nervous system schwannoma
Schmid, S., Mirchia, K., Tietze, A., Liu, I., Siewert, C., Nückles, J., Schittenhelm, J., Behling, F., Snuderl, M., Hartmann, C. J., et al. (2024) · Neuro-Oncology · doi:10.1093/neuonc/noae269 · Cited by 23
Talbot, J., Brion, R., Picarda, G. G. A., Amiaud, J., Chesneau, J., Bougras-Cartron, G., Stresing, V., Tirode, F., Heymann, D., Rédiní, F., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.01.001 · Cited by 21
Soft tissue sarcomas of infancy
Palumbo, J. S., & Zwerdling, T. (1999) · Seminars in Perinatology · doi:10.1016/s0146-0005(99)80038-x · Cited by 21
Primary Ewing sarcoma of the anterior mandible localized to the midline
Ko, E. M., Brouns, E. R. E. A., Korones, D. N., Pochal, W. F., Philipone, E., Zegarelli, D. J., & Yoon, A. J. (2013) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2012.11.010 · Cited by 21
Clinical and biological significance of hepatoma‐derived growth factor in Ewing's sarcoma
Yang, Y., Li, H., Zhang, F., Shi, H., Zhen, T., Dai, S., Kang, L., Liang, Y.-J., Wang, J., & Han, A. (2013) · The Journal of Pathology · doi:10.1002/path.4241 · Cited by 21
“Ewing’s sarcoma is characterized by the presence of chromosomal rearrangements of the EWS gene with ETS -related genes, resulting in the production of chimeric transcription factors [1].”
BackgroundDimerization and DNA recognition rules of mithramycin and its analogues
Weidenbach, S., Hou, C., Chen, J., Tsodikov, O. V., & Rohr, J. (2015) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2015.12.011 · Cited by 21
Precision medicine in Ewing sarcoma: a translational point of view
Gargallo, P., Juan, A. D., Yáñez, Y., Dolz, S., Segura, V., Castel, V., & Cañete, A. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-020-02298-7 · Cited by 22
Wei, J., Liu, X., Li, T., Xing, P., Zhang, C., & Yang, J. (2020) · Journal of Cancer · doi:10.7150/jca.42816 · Cited by 21
“ES is characterized by chromosomal translocation of the EWS gene to locations carrying different ETS-related genes [113, 114].”
BackgroundCOVID-19 biomarkers and their overlap with comorbidities in a disease biomarker data model
Gogate, N., Lyman, D., Bell, A. L., Cauley, E. S., Crandall, K. A., Joseph, A., Kahsay, R., Natale, D. A., Schriml, L. M., Sen, S., et al. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab191 · Cited by 23
The CAM Model for CIC-DUX4 Sarcoma and Its Potential Use for Precision Medicine
Komatsu, A., Matsumoto, K., Yoshimatsu, Y., Sin, Y., Kubota, A., Saito, T., Mizumoto, A., Ohashi, S., Muto, M., Noguchi, R., et al. (2021) · Cells · doi:10.3390/cells10102613 · Cited by 21
“While Ewing sarcoma harbors a fusion gene that is formed by the fusion of the EWSR1 gene to the ETS gene family [6,7], CDS is characterized by the occurrence of a fusion gene CIC-DUX4 that is formed by the fusion of CIC (Capicua) and DUX4 (Double homeobox 4 gene).”
BackgroundCharacterization of a new brain‐specific isoform of the EWS oncoprotein
Melot, T., Dauphinot, L., Sévenet, N., Radvanyi, F., & Delattre, O. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02251.x · Cited by 23
Self-citationAntitumor Vectorized Oligonucleotides in a Model of Ewing Sarcoma: Unexpected Role of Nanoparticles
Elhamess, H., Bertrand, J., Maccario, J., Maksimenko, A., & Malvy, C. (2009) · Oligonucleotides · doi:10.1089/oli.2009.0197 · Cited by 21
“A cquired clonal chromosomal abnormalities are found in the malignant cells of most patients with leukemia, lymphoma, and solid tumors (Delattre et al., 1992; Rabbitts, 1994).”
Regulation of apoptosis and proliferation in Ewing's sarcoma—opportunities for targeted therapy
Kontny, U. (2006) · Hematological Oncology · doi:10.1002/hon.766 · Cited by 24
“for an RNA-binding protein, with a member of the ETS family of transcription factors is thought to be the primordial step in tumor pathogenesis [2].”
BackgroundInfluentialCurrent Approach to Pediatric Soft Tissue Sarcomas
Merchant, M. S., & Mackall, C. L. (2009) · The Oncologist · doi:10.1634/theoncologist.2009-0160 · Cited by 21
Regulation of Stem Cell Self-Renewal and Oncogenesis by RNA-Binding Proteins
Hattori, A., Buac, K., & Ito, T. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-29073-7_7 · Cited by 23
EWSR 1/ ELF 5 induces acute myeloid leukemia by inhibiting p53/p21 pathway
Endo, A., Tomizawa, D., Aoki, Y., Morio, T., Mizutani, S., & Takagi, M. (2016) · Cancer Science · doi:10.1111/cas.13080 · Cited by 21
Bochert, M. A., Kleinbaum, L. A., Sun, L.-Y., & Burton, F. H. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8560 · Cited by 21
Yabe, H., Fukuma, M., Urano, F., Yoshida, K., Kato, S., Toyama, Y., Hata, J.-I., & Umezawa, A. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00129-8 · Cited by 21
Pediatric malignancies provide unique cancer therapy targets
�ren, A., & Toretsky, J. A. (2005) · Current Opinion in Pediatrics · doi:10.1097/01.mop.0000147904.84978.ae · Cited by 21
Zoubek, A., Simonitsch, I., Panzer‐Grümayer, E. R., Ghali, D., Pfleiderer, C., Haas, O. A., Mann, G., Lang, S., Radaszkiewicz, T., Gadner, H., et al. (1995) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(95)00014-3 · Cited by 21
Self-citationThe human archain gene, ARCN1, has highly conserved homologs in rice and drosophila
Radice, P., Pensotti, V., Jones, C., Perry, H., Pierotti, M. A., & Tunnacliffe, A. (1995) · Genomics · doi:10.1016/0888-7543(95)80087-3 · Cited by 21
The Oncogenic TLS-ERG Fusion Protein Exerts Different Effects in Hematopoietic Cells and Fibroblasts
Zou, J., Ichikawa, H., Blackburn, M. L., Hu, H., Zielinska‐Kwiatkowska, A., Mei, Q., Roth, G. J., Chansky, H. A., & Yang, L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.14.6235-6246.2005 · Cited by 22
“None of the listed genes in Table 1 has been found to be the target of EWS-ETS fusion proteins, suggesting that TLS-ERG mediates transformation of hematopoietic and nonhematopoietic cells through different pathways.”
BackgroundInfluentialPeripheral Primitive Neuroectodermal Tumor of the Jugular Foramen: Case Report
Yamazaki, T., Kuroki, T., Katsume, M., & Kameda, N. (2002) · Neurosurgery · doi:10.1097/00006123-200211000-00028 · Cited by 21
“EWS-ETS gene fusion (3); that is to say, these tumors share a specific cytogenetic aberration.”
BackgroundELF-1 Interacts with and Transactivates the IgH Enhancer π Site
Akbarali, Y., Oettgen, P., Boltax, J., & Libermann, T. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.42.26007 · Cited by 23
Characterization of the human and mouse Fli-1 promoter regions
Barbeau, B., Bergeron, D., Beaulieu, J., Nadjem, Z., & Rassart, É. (1996) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(96)00060-7 · Cited by 24
AnEWS/ERG fusion with a truncated N-terminal domain ofEWS in a Ewing's tumor
Peter, M., Mugneret, F., Aurias, A., Thomas, G. D., Magdelénat, H., & Delattre, O. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960729)67:3<339::aid-ijc6>3.0.co;2-s · Cited by 29
Self-citationMiehlke, S., Kirsch, C., Agha‐Amiri, K., Günther, T., Lehn, N., Malfertheiner, P., Stolte, M., Ehninger, G., & Bayerdörffer, E. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000801)87:3<438::aid-ijc20>3.0.co;2-1 · Cited by 200
Richardson, S. A., Gulati, G., Harker, P. J. B., Redfern, A., Pearce, S. P., Karimpour, M., Hill, S. M., Makeev, V. J., Brennan, B., Lee, A. T., et al. (2025) · doi:10.1101/2025.04.25.25325254
Metadata
- Authors
- Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., Aurias, A., & Thomas, G.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Venue
- Nature
- Published
- 1992-09
- Volume
- 359
- Issue
- 6391
- Pages
- 162-165
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2069351898
- Cited by
- 1,907
- References
- 30
- Citations by year
- 2026: 57 · 2025: 72 · 2024: 69 · 2023: 64 · 2022: 78 · 2021: 83 · 2020: 80 · 2019: 69 · 2018: 54 · 2017: 57 · 2016: 71 · 2015: 62 · 2014: 61 · 2013: 63 · 2012: 45
- FWCI
- 60.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- Ewing sarcoma, primitive neuroectodermal tumor, 22)(q24, EWSR1, gene fusion, chromosomal translocation, RNA-binding domain
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Chromosomes, Human, Pair 11, Chromosomes, Human, Pair 22, Cloning, Molecular, Gene Frequency, Humans, Molecular Sequence Data, Nucleic Acid Hybridization, Sarcoma, Ewing, Sequence Homology, Nucleic Acid, Transcription, Genetic, Translocation, Genetic, Restriction Mapping, DNA Probes, Polymerase Chain Reaction, Open Reading Frames, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.